266 related articles for article (PubMed ID: 19859769)
1. Predictive factors of response to decongestive therapy in patients with breast-cancer-related lymphedema.
Forner-Cordero I; Muñoz-Langa J; Forner-Cordero A; DeMiguel-Jimeno JM
Ann Surg Oncol; 2010 Mar; 17(3):744-51. PubMed ID: 19859769
[TBL] [Abstract][Full Text] [Related]
2. Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy.
Vignes S; Porcher R; Arrault M; Dupuy A
Breast Cancer Res Treat; 2007 Mar; 101(3):285-90. PubMed ID: 16826318
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of response to intensive decongestive physiotherapy in upper limb lymphedema after breast cancer treatment: a cohort study.
Vignes S; Porcher R; Champagne A; Dupuy A
Breast Cancer Res Treat; 2006 Jul; 98(1):1-6. PubMed ID: 16752081
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of lymphedema severity and response to CDP in breast cancer-related lymphedema (BCRL).
Liao SF; Li SH; Huang HY; Chen ST; Kuo SJ; Chen DR; Wei TS
Breast; 2013 Oct; 22(5):703-6. PubMed ID: 23321586
[TBL] [Abstract][Full Text] [Related]
5. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.
Shih YC; Xu Y; Cormier JN; Giordano S; Ridner SH; Buchholz TA; Perkins GH; Elting LS
J Clin Oncol; 2009 Apr; 27(12):2007-14. PubMed ID: 19289624
[TBL] [Abstract][Full Text] [Related]
6. Comparing two treatment methods for post mastectomy lymphedema: complex decongestive therapy alone and in combination with intermittent pneumatic compression.
Haghighat S; Lotfi-Tokaldany M; Yunesian M; Akbari ME; Nazemi F; Weiss J
Lymphology; 2010 Mar; 43(1):25-33. PubMed ID: 20552817
[TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow stromal cells transplantation for the treatment of secondary arm lymphedema: a prospective controlled study in patients with breast cancer related lymphedema.
Hou C; Wu X; Jin X
Jpn J Clin Oncol; 2008 Oct; 38(10):670-4. PubMed ID: 18776199
[TBL] [Abstract][Full Text] [Related]
8. Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression.
Szuba A; Achalu R; Rockson SG
Cancer; 2002 Dec; 95(11):2260-7. PubMed ID: 12436430
[TBL] [Abstract][Full Text] [Related]
9. Effect of complex decongestive therapy on edema and the quality of life in breast cancer patients with unilateral leymphedema.
Kim SJ; Yi CH; Kwon OY
Lymphology; 2007 Sep; 40(3):143-51. PubMed ID: 18062617
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of response to CDP in lower limb lymphedema (LLL) after pelvic cancer treatment.
Liao SF; Li SH; Huang HY
Gynecol Oncol; 2012 Jun; 125(3):712-5. PubMed ID: 22426250
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors of response to phase I complete decongestive therapy in upper extremity lymphedema following breast carcinoma in Iran.
Haghighat S; Lotfi-Tokaldany M; Maboudi AA; Karami M; Bahadori A; Weiss J
Lymphology; 2013 Jun; 46(2):97-104. PubMed ID: 24354108
[TBL] [Abstract][Full Text] [Related]
12. Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer.
Hamner JB; Fleming MD
Ann Surg Oncol; 2007 Jun; 14(6):1904-8. PubMed ID: 17342565
[TBL] [Abstract][Full Text] [Related]
13. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors.
Fu MR; Chen CM; Haber J; Guth AA; Axelrod D
Ann Surg Oncol; 2010 Jul; 17(7):1847-53. PubMed ID: 20140528
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of complete decongestive therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer.
Koul R; Dufan T; Russell C; Guenther W; Nugent Z; Sun X; Cooke AL
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):841-6. PubMed ID: 17175115
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for development of lymphedema following breast cancer treatment.
Deo SV; Ray S; Rath GK; Shukla NK; Kar M; Asthana S; Raina V
Indian J Cancer; 2004; 41(1):8-12. PubMed ID: 15105573
[TBL] [Abstract][Full Text] [Related]
16. Study of edema reduction patterns during the treatment phase of complex decongestive physiotherapy for extremity lymphedema.
Yamamoto T; Todo Y; Kaneuchi M; Handa Y; Watanabe K; Yamamoto R
Lymphology; 2008 Jun; 41(2):80-6. PubMed ID: 18720915
[TBL] [Abstract][Full Text] [Related]
17. Compression therapy in breast cancer-related lymphedema: A randomized, controlled comparative study of relation between volume and interface pressure changes.
Damstra RJ; Partsch H
J Vasc Surg; 2009 May; 49(5):1256-63. PubMed ID: 19394553
[TBL] [Abstract][Full Text] [Related]
18. Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy.
Mondry TE; Riffenburgh RH; Johnstone PA
Cancer J; 2004; 10(1):42-8; discussion 17-9. PubMed ID: 15000494
[TBL] [Abstract][Full Text] [Related]
19. Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.
Gothard L; Cornes P; Earl J; Hall E; MacLaren J; Mortimer P; Peacock J; Peckitt C; Woods M; Yarnold J
Radiother Oncol; 2004 Nov; 73(2):133-9. PubMed ID: 15542159
[TBL] [Abstract][Full Text] [Related]
20. Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study.
Teas J; Cunningham JE; Cone L; Jansen K; Raghavan SK; Nitcheva DK; Xie D; Butler WM
J Womens Health (Larchmt); 2004 Nov; 13(9):1008-18. PubMed ID: 15665658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
